new antiepileptic, Gabitril (tiagabine)
November 1997
Abbott is introducing a new antiepileptic, Gabitril (tiagabine). It's coming out now in the U.S...next year in Canada.
Gabitril will be used as add-on therapy for partial seizures.
It's thought to work by blocking the reuptake of GABA...the major inhibitory neurotransmitter in the CNS. The increased GABA levels "apply the brakes" to inhibit seizures.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive